Teradyne price target raised to $124 from $115 at Craig-Hallum

Craig-Hallum raised the firm’s price target on Teradyne to $124 from $115 and keeps a Buy rating on the shares. Teradyne reported better than expected results and Q2 guidance with increasing strength for AI-driven semiconductor test, the analyst tells investors in a research note. The firm is encouraged by the strong AI-drive results and believes investors could increasingly make Teradyne an AI infrastructure play given its benefits from the AI mega trends and shares that have traded relatively flat for the last couple years.